CEO
InsightRX
Dr. Sirj Goswami, PhD, currently serves as the CEO and Co-founder of InsightRx, a software company dedicated to enhancing therapeutic outcomes through the integration of quantitative pharmacology and artificial intelligence. Sirj earned his PhD from the Department of Bioengineering and Therapeutic Sciences at the University of California, San Francisco. His research focused on creating innovative methodologies that combine pharmacogenomics and pharmacometrics to pinpoint genetic variants predictive of long-term responses to diabetes medications. At InsightRx, he has led the development and implementation of model-informed precision dosing applications across health systems worldwide. A member of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) since 2010, Sirj has also played a key role in establishing the precision dosing community and served as its first chair.
Disclosure(s): No financial relationships to disclose